J
Jay S. Skyler
Researcher at University of Miami
Publications - 342
Citations - 21966
Jay S. Skyler is an academic researcher from University of Miami. The author has contributed to research in topics: Diabetes mellitus & Type 1 diabetes. The author has an hindex of 69, co-authored 334 publications receiving 19377 citations. Previous affiliations of Jay S. Skyler include Katholieke Universiteit Leuven & Duke University.
Papers
More filters
Journal ArticleDOI
Intensive glycemic control and the prevention of cardiovascular events: implications of the ACCORD, ADVANCE, and VA Diabetes Trials: a position statement of the American Diabetes Association and a scientific statement of the American College of Cardiology Foundation and the American Heart Association.
Jay S. Skyler,Richard M. Bergenstal,Robert O. Bonow,John B. Buse,Prakash Deedwania,Edwin A M Gale,Barbara V. Howard,M. Sue Kirkman,Mikhail Kosiborod,Peter D. Reaven,Robert S. Sherwin +10 more
TL;DR: Results from randomized controlled trials have demonstrated conclusively that the risk of microvascular complications can be reduced by intensive glycemic control in patients with type 1 and type 2 diabetes, leading the American Diabetes Association to recommend an A1C goal of <7% for most adults with diabetes.
Journal ArticleDOI
Rituximab, B-Lymphocyte Depletion, and Preservation of Beta-Cell Function
Mark D. Pescovitz,Carla J. Greenbaum,Heidi Krause-Steinrauf,Dorothy J. Becker,Stephen E. Gitelman,Robin Goland,Peter A. Gottlieb,Jennifer B. Marks,Paula McGee,Antoinette Moran,Philip Raskin,Henry Rodriguez,Desmond A. Schatz,Diane K. Wherrett,Darrell M. Wilson,John M. Lachin,Jay S. Skyler +16 more
TL;DR: The finding that B lymphocytes contribute to the pathogenesis of type 1 diabetes may open a new pathway for exploration in the treatment of patients with this condition.
Journal ArticleDOI
Effects of insulin in relatives of patients with type 1 diabetes mellitus
Jay S. Skyler,D. Brown,H. P. Chase,E. Collier,C. Cowie,George S. Eisenbarth,J. Fradkin,G. Grave,Greenbaum Cj,R. A. Jackson,F. R. Kaufman,J. P. Krischer,Jennifer B. Marks,J. P. Palmer,A. T. Ricker,Desmond A. Schatz,Darrell M. Wilson,W. E. Winter,J. Wolfsdorf,A. Zeidler,H. Dickler,R. C. Eastman,N. K. Maclaren,J. I. Malone,P. R. Robertson,D. Cuthbertson,L. M. Rafkin-Mervis,K. Herold,Lisa Rafkin-Mervis,B. Aneju,D. Conboy,Rebecca J. Cook,M. A. Dennis,L. Finney,S. Harris,Della Matheson,M. McCulloch-Olsen,T. Smith,J. Valenzuela,N. Vega,O. B. Crofford,D. DeMets,John M. Lachin,A. Rossini,A. Schiffrin,M. Steffes,Anastasios A. Tsiatis,B. Zinman +47 more
Journal ArticleDOI
Practical recommendations for the management of diabetes in patients with COVID-19.
Stefan R. Bornstein,Francesco Rubino,Francesco Rubino,Kamlesh Khunti,Geltrude Mingrone,Geltrude Mingrone,David Hopkins,David Hopkins,Andreas L. Birkenfeld,Bernhard O. Boehm,Bernhard O. Boehm,Stephanie A. Amiel,Richard I. G. Holt,Jay S. Skyler,J. Hans DeVries,Eric Renard,Robert H. Eckel,Paul Zimmet,Kurt George Alberti,Josep Vidal,Bruno Geloneze,Juliana C.N. Chan,Linong Ji,Barbara Ludwig +23 more
TL;DR: An international panel of experts in the field of diabetes and endocrinology is formed to provide some guidance and practical recommendations for the management of diabetes during the COVID-19 pandemic.
Journal ArticleDOI
Staging Presymptomatic Type 1 Diabetes: A Scientific Statement of JDRF, the Endocrine Society, and the American Diabetes Association.
Richard A. Insel,Jessica L. Dunne,Mark A. Atkinson,Jane L. Chiang,Dana Dabelea,Peter A. Gottlieb,Carla J. Greenbaum,Kevan C. Herold,Jeffrey P. Krischer,Åke Lernmark,Robert E. Ratner,Marian Rewers,Desmond A. Schatz,Jay S. Skyler,Jay M. Sosenko,Anette-G. Ziegler +15 more
TL;DR: Adoption of this staging classification provides a standardized taxonomy for type 1 diabetes and will aid the development of therapies and the design of clinical trials to prevent symptomatic disease, promote precision medicine, and provide a framework for an optimized benefit/risk ratio.